Press Release

We will start joint research with Mochida Pharmaceutical Co. ,Ltd

2022.11.01

On October 31, 2022, we signed a joint research agreement with Mochida Pharmaceutical Co. Ltd.

In this joint research, we will combine our stem cell technology with Mochida’s scaffold material (biomaterials) technology to develop better regenerative medicine products.

We reported the financial results at the regular general meeting of shareholders.
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).

Latest posts

2023.11.29 News
Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).
2023.10.31 Press Release
The 8th Annual General Meeting of Shareholders was held.
2023.07.13 News
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
2023.06.22 News
Notice of website maintenance
2023.06.01 IR
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
2022.11.01 Press Release
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
2022.10.30 Press Release
We reported the financial results at the regular general meeting of shareholders.
2021.11.01 IR
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
2021.09.01 R&D
Research and development of exosomes will be resumed.
2021.03.16 News
“ACHIEVEMENTS” Page has been updated.

Latest posts

Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).

The 8th Annual General Meeting of Shareholders was held.

Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).

Notice of website maintenance

Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).

We will start joint research with Mochida Pharmaceutical Co. ,Ltd

We reported the financial results at the regular general meeting of shareholders.

Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding

Research and development of exosomes will be resumed.

“ACHIEVEMENTS” Page has been updated.